All tenders
75N93018C00023
IGF::OT::IGF - "DEVELOPMENT OF A SMALL MOLECULE DRUG ANTI-TOXIN THERAPEUTIC TO TREAT ANTHRAX IN HUMANS."
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75N93018C00023
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- IGF::OT::IGF - "DEVELOPMENT OF A SMALL MOLECULE DRUG ANTI-TOXIN THERAPEUTIC TO TREAT ANTHRAX IN HUMANS."
- Source
- USASpending (Federal)
- Source ID
- usa-75N93018C00023
Details
- Location
- United States
Description
IGF::OT::IGF - "DEVELOPMENT OF A SMALL MOLECULE DRUG ANTI-TOXIN THERAPEUTIC TO TREAT ANTHRAX IN HUMANS." Awarded to: HAWAII BIOTECH, INC. Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2018/09/20 12:00:00 AM UTC
- Closing date
- 2025/07/22 12:00:00 AM UTC
Estimated value
$24.6M USD
Classification
Normalized category
Other